Cabaletta Bio Net Worth
Cabaletta Bio Net Worth Breakdown | CABA |
Cabaletta Bio Net Worth Analysis
Cabaletta Bio's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Cabaletta Bio's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Cabaletta Bio's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Cabaletta Bio's net worth analysis. One common approach is to calculate Cabaletta Bio's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Cabaletta Bio's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Cabaletta Bio's net worth. This approach calculates the present value of Cabaletta Bio's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Cabaletta Bio's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Cabaletta Bio's net worth. This involves comparing Cabaletta Bio's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Cabaletta Bio's net worth relative to its peers.
Enterprise Value |
|
To determine if Cabaletta Bio is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Cabaletta Bio's net worth research are outlined below:
| Cabaletta Bio generated a negative expected return over the last 90 days | |
| Cabaletta Bio has high historical volatility and very poor performance | |
| Net Loss for the year was (67.67 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Cabaletta Bio currently holds about 96.81 M in cash with (53.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.34, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Cabaletta Bio has a poor financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Cabaletta Bios SWOT analysis CAR-T pioneers stock faces pivotal moment - Investing.com |
Cabaletta Bio uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Cabaletta Bio. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Cabaletta Bio's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Cabaletta Bio's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Cabaletta Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cabaletta Bio backward and forwards among themselves. Cabaletta Bio's institutional investor refers to the entity that pools money to purchase Cabaletta Bio's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Sofinnova Ventures | 2024-06-30 | 1.2 M | Commodore Capital Lp | 2024-09-30 | 1.1 M | Geode Capital Management, Llc | 2024-09-30 | 1.1 M | Jpmorgan Chase & Co | 2024-06-30 | 956.7 K | Millennium Management Llc | 2024-06-30 | 698.3 K | Point72 Asset Management, L.p. | 2024-09-30 | 667.3 K | Victory Capital Management Inc. | 2024-09-30 | 629.1 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 591 K | T. Rowe Price Associates, Inc. | 2024-06-30 | 582.3 K | Jennison Associates Llc | 2024-09-30 | 5.6 M | Blackrock Inc | 2024-06-30 | 4.8 M |
Follow Cabaletta Bio's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 111.93 M.Market Cap |
|
Project Cabaletta Bio's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.27) | (0.28) | |
| Return On Capital Employed | (0.31) | (0.30) | |
| Return On Assets | (0.27) | (0.28) | |
| Return On Equity | (0.29) | (0.27) |
When accessing Cabaletta Bio's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Cabaletta Bio's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Cabaletta Bio's profitability and make more informed investment decisions.
Please note, the presentation of Cabaletta Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cabaletta Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Cabaletta Bio's management manipulating its earnings.
Evaluate Cabaletta Bio's management efficiency
Cabaletta Bio has return on total asset (ROA) of (0.3113) % which means that it has lost $0.3113 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4816) %, meaning that it created substantial loss on money invested by shareholders. Cabaletta Bio's management efficiency ratios could be used to measure how well Cabaletta Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of November 27, 2024, Return On Tangible Assets is expected to decline to -0.28. The current year's Return On Capital Employed is expected to grow to -0.3. At present, Cabaletta Bio's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 9.6 M, whereas Net Tangible Assets are forecasted to decline to about 84 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 5.77 | 6.06 | |
| Tangible Book Value Per Share | 5.77 | 6.06 | |
| Enterprise Value Over EBITDA | (10.12) | (9.62) | |
| Price Book Value Ratio | 3.94 | 4.13 | |
| Enterprise Value Multiple | (10.12) | (9.62) | |
| Price Fair Value | 3.94 | 4.13 | |
| Enterprise Value | 224.2 M | 153.2 M |
Cabaletta Bio's management has consistently demonstrated strong leadership, driving both financial growth and operational excellence. By analyzing current market trends and future growth opportunities, we assess the stock's true value and potential for investors.
Return On Equity (0.48) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cabaletta Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cabaletta Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cabaletta Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cabaletta Bio Corporate Filings
8K | 18th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
13A | 22nd of August 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
| 23rd of April 2024 Other Reports | ViewVerify |
Cabaletta Bio Earnings per Share Projection vs Actual
Cabaletta Bio Corporate Management
| Samik MD | Chief Officer | Profile | |
| Steven MD | Chairman, CoFounder | Profile | |
| FACR MD | Chief Officer | Profile | |
| Michael JD | General Secretary | Profile | |
| Heather MSc | Chief Officer | Profile | |
| Qing Yuan | Chief Officer | Profile | |
| Aimee MD | CoFounder Board | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. If investors know Cabaletta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cabaletta Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.16) | Return On Assets (0.31) | Return On Equity (0.48) |
The market value of Cabaletta Bio is measured differently than its book value, which is the value of Cabaletta that is recorded on the company's balance sheet. Investors also form their own opinion of Cabaletta Bio's value that differs from its market value or its book value, called intrinsic value, which is Cabaletta Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cabaletta Bio's market value can be influenced by many factors that don't directly affect Cabaletta Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cabaletta Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cabaletta Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.